Genetic Technologies hires new CFO
Genetic Technologies (ASX:GTG) has appointed Eutillio Buccilli as its latest chief financial officer (CFO).
Buccilli has had more than 35 years of senior management experience in the financial services, contracting and recruitment, property and retail industries in both Australia and the USA.
He has previously worked at major companies including Coles Myer, General Electric and Challenger Limited. Through his career, he has accrued financial, corporate governance and commercial experience.
In March, GTG announced the results of a simulation study showing that its BREVAGen breast cancer risk assessment tool is a cost-effective way to direct tamoxifen chemoprevention. The company also entered another settlement and licensing deal as part of its US patent enforcement efforts.
Genetic Technologies (ASX:GTG) shares were trading unchanged at $0.04 as of around 1 pm on Wednesday.
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
